Great Valley Advisor Group’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $206K | Sell |
2,492
-258
| -9% | -$21.3K | ﹤0.01% | 860 |
|
|
2025
Q1 | $223K | Sell |
2,750
-129
| -4% | -$10.5K | ﹤0.01% | 805 |
|
|
2024
Q4 | $260K | Sell |
2,879
-535
| -16% | -$48.2K | 0.01% | 735 |
|
|
2024
Q3 | $337K | Buy |
3,414
+746
| +28% | +$73.7K | 0.01% | 657 |
|
|
2024
Q2 | $247K | Sell |
2,668
-556
| -17% | -$51.5K | 0.01% | 694 |
|
|
2024
Q1 | $306K | Buy |
3,224
+719
| +29% | +$68.1K | 0.01% | 605 |
|
|
2023
Q4 | $224K | Sell |
2,505
-2,563
| -51% | -$229K | 0.01% | 648 |
|
|
2023
Q3 | $370K | Buy |
5,068
+474
| +10% | +$34.6K | 0.02% | 503 |
|
|
2023
Q2 | $383K | Buy |
4,594
+1,070
| +30% | +$89.1K | 0.02% | 503 |
|
|
2023
Q1 | $268K | Buy |
3,524
+422
| +14% | +$32.1K | 0.01% | 575 |
|
|
2022
Q4 | $257K | Buy |
+3,102
| New | +$257K | 0.01% | 586 |
|
|
2022
Q1 | – | Sell |
-2,319
| Closed | -$273K | – | 634 |
|
|
2021
Q4 | $273K | Sell |
2,319
-605
| -21% | -$71.2K | 0.02% | 508 |
|
|
2021
Q3 | $367K | Sell |
2,924
-356
| -11% | -$44.7K | 0.03% | 423 |
|
|
2021
Q2 | $445K | Sell |
3,280
-1,116
| -25% | -$151K | 0.03% | 376 |
|
|
2021
Q1 | $596K | Sell |
4,396
-2,117
| -33% | -$287K | 0.06% | 271 |
|
|
2020
Q4 | $917K | Buy |
6,513
+3,128
| +92% | +$440K | 0.09% | 195 |
|
|
2020
Q3 | $378K | Sell |
3,385
-7,025
| -67% | -$784K | 0.05% | 293 |
|
|
2020
Q2 | $1.17M | Buy |
10,410
+5,589
| +116% | +$625K | 0.19% | 134 |
|
|
2020
Q1 | $373K | Buy |
+4,821
| New | +$373K | 0.1% | 213 |
|